Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Auckland UniServices Ltd.

Latest From Auckland UniServices Ltd.

Recent Tech Transfer Deals (06/11)

Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.

Centella pursuing radiotherapy-boosting drug for hypoxic tumors under new deal

Centella Therapeutics gained the rights to an investigational drug from New Zealand-based Auckland UniServices designed to pump up the effectiveness of radiotherapy and chemotherapy used to treat oxygen-starved, or hypoxic, solid tumors.

Cancer New Zealand

Trans-Tasman chooses pharma for first investment

A new joint Australia/New Zealand fund to support the commercialisation of intellectual property deriving from academic research has made its first investment, in an oncology therapeutics venture.

Cancer New Zealand

New Zealand Biotech

The other land down under is getting serious about moving its affordable world-class science to global markets. For start-ups, establishing a US presence may be key. The three NZ start-ups that we profile in this issue--CoDa Therapeutics, Proacta and Protemix--have found their own paths for taking their technologies to the worldwide market via a US presence.

BioPharmaceutical Middle East and Africa
See All

Company Information

  • Industry
  • Academic and Research Institutions